Novartis Pharma President Marie-France Tschudin On Inclisiran, Launches And More

 
• By Jessica Merrill

Tschudin talked to Scrip about taking over as Novartis Pharmaceuticals president, why inclisiran is different from marketed PCSK9 inhibitors and prioritizing investment behind multiple new launches.

Marie France Tschudin
Marie France Tschudin took over from Paul Hudson, who is now Sanofi's CEO • Source: Shutterstock

More from Leadership

More from Scrip